170 related articles for article (PubMed ID: 37410340)
21. Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems.
Wadhwa A; Roscoe C; Duran EA; Kwan L; Haroldsen CL; Shelton JB; Cullen J; Knudsen BS; Rettig MB; Pyarajan S; Nickols NG; Maxwell KN; Yamoah K; Rose BS; Rebbeck TR; Iyer HS; Garraway IP
JAMA Netw Open; 2024 Mar; 7(3):e242852. PubMed ID: 38502125
[TBL] [Abstract][Full Text] [Related]
22. Racial differences in quality of life following prostate cancer diagnosis.
Halbert CH; Coyne J; Weathers B; Mahler B; Delmoor E; Vaughn D; Malkowicz SB; Lee D; Troxel A
Urology; 2010 Sep; 76(3):559-64. PubMed ID: 20207396
[TBL] [Abstract][Full Text] [Related]
23. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors.
Kurian CJ; Leader AE; Thong MSY; Keith SW; Zeigler-Johnson CM
BMC Public Health; 2018 Aug; 18(1):1060. PubMed ID: 30139347
[TBL] [Abstract][Full Text] [Related]
24. Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women.
Heller DR; Axelrod B; Sevilimedu V; Morrow M; Mehrara BJ; Barrio AV
JAMA Surg; 2024 Mar; ():. PubMed ID: 38536186
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.
Vince RA; Jiang R; Bank M; Quarles J; Patel M; Sun Y; Hartman H; Zaorsky NG; Jia A; Shoag J; Dess RT; Mahal BA; Stensland K; Eyrich NW; Seymore M; Takele R; Morgan TM; Schipper M; Spratt DE
JAMA Netw Open; 2023 Jan; 6(1):e2250416. PubMed ID: 36630135
[TBL] [Abstract][Full Text] [Related]
26. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
[TBL] [Abstract][Full Text] [Related]
27. Church Attendance and Mobility Limitation Among Black and White Men With Prostate Cancer.
Bruce MA; Bowie JV; Beech BM; Norris KC; LaVeist TA; Howard DL; Thorpe RJ
Am J Mens Health; 2021; 15(1):1557988321993560. PubMed ID: 33576283
[TBL] [Abstract][Full Text] [Related]
28. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
29. Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized Trial.
Langlais CS; Chen YH; Van Blarigan EL; Kenfield SA; Kessler ER; Daniel K; Ramsdill JW; Beer TM; Graff RE; Paich K; Chan JM; Winters-Stone KM
Integr Cancer Ther; 2022; 21():15347354211063500. PubMed ID: 35389288
[TBL] [Abstract][Full Text] [Related]
30. Change in quality of life over eight years in a nationally representative sample of US adults with heart disease and type 2 diabetes:minority race and toxic stress as keysocial determinants.
Nkwata AK; Song X; Zhang M; Ezeamama AE
BMC Public Health; 2020 May; 20(1):684. PubMed ID: 32410708
[TBL] [Abstract][Full Text] [Related]
31. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial.
Delforge M; Patel K; Eliason L; Dhanda D; Shi L; Guo S; Marshall TS; Arnulf B; Cavo M; Nooka A; Manier S; Callander N; Giralt S; Einsele H; Ailawadhi S; Popa McKiver M; Cook M; Rodríguez-Otero P
Lancet Haematol; 2024 Mar; 11(3):e216-e227. PubMed ID: 38423700
[TBL] [Abstract][Full Text] [Related]
33. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
[TBL] [Abstract][Full Text] [Related]
34. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
Nyame YA; Holt SK; Etzioni RD; Gore JL
Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
[TBL] [Abstract][Full Text] [Related]
35. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
36. Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer.
Senft N; Hamel LM; Manning MA; Kim S; Penner LA; Moore TF; Carducci MA; Heath EI; Lansey DG; Albrecht TL; Wojda M; Jordan A; Eggly S
JAMA Oncol; 2020 Nov; 6(11):1773-1777. PubMed ID: 32940630
[TBL] [Abstract][Full Text] [Related]
37. Quality of Life Among Black Prostate Cancer Survivors: An Integrative Review.
Dickey SL; Ogunsanya ME
Am J Mens Health; 2018 Sep; 12(5):1648-1664. PubMed ID: 29926761
[TBL] [Abstract][Full Text] [Related]
38. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
[TBL] [Abstract][Full Text] [Related]
39. Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
DeWitt-Foy ME; Gam K; Modlin C; Kim SP; Abouassaly R
J Urol; 2021 Feb; 205(2):426-433. PubMed ID: 33226309
[TBL] [Abstract][Full Text] [Related]
40. Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study.
Abdollah F; Sammon JD; Majumder K; Reznor G; Gandaglia G; Sood A; Hevelone N; Kibel AS; Nguyen PL; Choueiri TK; Selvaggi KJ; Menon M; Trinh QD
J Natl Compr Canc Netw; 2015 Sep; 13(9):1131-8. PubMed ID: 26358797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
